Key facts
- It has raised $14.1M; the latest was Later Stage VC ($14.1M) in Dec 2025.
- Notable investors include China Nuclear Industry Fund Management.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for CNNC Particle
- ·The full record, as it builds
Funding rounds
No funding rounds for CNNC Particle are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CNNC Particle
Manufacturer of nuclear medical equipment intended to advance precision diagnosis and targeted radiotherapy for medical institutions. The company offers medical linear accelerators, nuclear medicine imaging devices with SPECT/3D optical fusion technology, and BNCT equipment, enabling hospitals and cancer treatment centres to deliver accurate, individualised, and efficient patient care.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2019
- Employees
- 150
- Ownership
- Privately Held (backing)
CNNC Particle doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CNNC Particle shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CNNC Particle in its N-PORT filings yet. We sweep new filings monthly.